Diagnosis and management of posterior cortical atrophy

KXX Yong, J Graff-Radford, S Ahmed… - … treatment options in …, 2023 - Springer
Purpose of review The study aims to provide a summary of recent developments for
diagnosing and managing posterior cortical atrophy (PCA). We present current efforts to …

Atypical presentations of Alzheimer disease

D Jones, V Pelak, E Rogalski - CONTINUUM: Lifelong Learning in …, 2024 - journals.lww.com
OBJECTIVE This article provides a comprehensive review of the distinct features of four
atypical Alzheimer disease (AD) variants: dysexecutive AD, behavioral variant AD, posterior …

Deciphering the clinico-radiological heterogeneity of dysexecutive Alzheimer's disease

N Corriveau-Lecavalier, LR Barnard, J Lee… - Cerebral …, 2023 - academic.oup.com
Dysexecutive Alzheimer's disease (dAD) manifests as a progressive dysexecutive syndrome
without prominent behavioral features, and previous studies suggest clinico-radiological …

Divergent cortical tau positron emission tomography patterns among patients with preclinical Alzheimer disease

CB Young, JR Winer, K Younes, KA Cody… - JAMA …, 2022 - jamanetwork.com
Importance Characterization of early tau deposition in individuals with preclinical Alzheimer
disease (AD) is critical for prevention trials that aim to select individuals at risk for AD and …

Posterior cortical atrophy phenotypic heterogeneity revealed by decoding 18F-FDG-PET

RA Townley, H Botha, J Graff-Radford… - Brain …, 2021 - academic.oup.com
Posterior cortical atrophy is a neurodegenerative syndrome with a heterogeneous clinical
presentation due to variable involvement of the left, right, dorsal and ventral parts of the …

Phenotypic subtypes of progressive dysexecutive syndrome due to Alzheimer's disease: A series of clinical cases

N Corriveau-Lecavalier, MM Machulda, H Botha… - Journal of …, 2022 - Springer
Diagnostic criteria for a progressive dysexecutive syndrome due to Alzheimer's disease
(dAD) were proposed. Clinical observations suggest substantial variability in the clinico …

[HTML][HTML] Differential patterns of gray matter volumes and associated gene expression profiles in cognitively-defined Alzheimer's disease subgroups

C Groot, MJ Grothe, S Mukherjee, I Jelistratova… - NeuroImage: Clinical, 2021 - Elsevier
The clinical presentation of Alzheimer's disease (AD) varies widely across individuals but
the neurobiological mechanisms underlying this heterogeneity are largely unknown. Here …

Benson's disease or posterior cortical atrophy, revisited

O Yerstein, L Parand, LJ Liang, A Isaac… - Journal of …, 2021 - content.iospress.com
Background: D. Frank Benson and colleagues first described the clinical and
neuropathological features of posterior cortical atrophy (PCA) from patients in the UCLA …

Posterior cortical atrophy: clinical, neuroimaging, and neuropathological features

J Best, M Chapleau, GD Rabinovici - Expert Review of …, 2023 - Taylor & Francis
ABSTRACT Introduction Posterior Cortical Atrophy (PCA) is a neurodegenerative disorder
characterized by impairment of higher-order visual processing in the setting of progressive …

Greater white matter degeneration and lower structural connectivity in non-amnestic vs. amnestic Alzheimer's disease

JS Phillips, N Adluru, MK Chung… - Frontiers in …, 2024 - frontiersin.org
Introduction Multimodal evidence indicates Alzheimer's disease (AD) is characterized by
early white matter (WM) changes that precede overt cognitive impairment. WM changes …